Silicone Based Release Systems
The pharmacologic control of fertility as presently practiced requires a substantial motivational involvement on behalf of the user and interferes with far more of the reproductive process than is necessary to achieve an acceptable level of effectiveness. A solution to both of these problems can reside in the development of delivery systems for contraceptive drugs which necessitate less overt attention by the user and/or which deliver the contraceptives more selectively to the requisite target tissue.
KeywordsCupric Oxide Medroxyprogesterone Acetate Polyethylene Vinyl Acetate Overt Attention Sustained Release System
Unable to display preview. Download preview PDF.
- 1.Duncan, G. W. and Kalkwarf, D. R., in Human Reproduction: Conception and Contraception, E. S. Hafez and T. N. Evans, Eds., Harper & Row, New York, 1973.Google Scholar
- 5.Mishell, D. R. and Lumkin, M. E., Fertil. Steril., 21, 99 (1970).Google Scholar
- 6.Doyle, L. L. and Clewe, T. H., Amer. J. Obstet. Gynecol. 101, 564 (1968).Google Scholar
- 7.Scommegna, A., Pandya, G. N., Christ, M., Lee, A. W., and Cohen, M. R., Fertil. Steril., 21, 201 (1970).Google Scholar
- 8.Pharriss, B. B., in Intrauterine Devices: Development, Evaluation, and Program Implementation, R. G. Wheeler, G. W. Duncan, and J. J. Speidel, Eds., Academic Press, New York, 1974.Google Scholar